Advair (salmeterol xinafoate/fluticasone propionate)

pCPA File Number: 20736

Negotiation Status:

Concluded with an LOI

Indication(s):

Chronic Obstructive Pulmonary Disease and asthma

Sponsor/Manufacturer:

GlaxoSmithKline Inc.

CADTH Project Number:

Not Applicable

pCPA Engagement Letter Issued:

2014-10-06

Negotiation Process Concluded:

2015-02-03